260 related articles for article (PubMed ID: 24009420)
21. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
22. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
[TBL] [Abstract][Full Text] [Related]
23. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery.
Song J; Fan X; Shen Q
Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
Yue Y; Zhao D; Yin Q
Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
[TBL] [Abstract][Full Text] [Related]
25. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
[TBL] [Abstract][Full Text] [Related]
26. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
27. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
Singh A; Neupane YR; Mangla B; Kohli K
J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
29. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
Ali Z; Din FU; Zahid F; Sohail S; Imran B; Khan S; Malik M; Zeb A; Khan GM
BMC Pharmacol Toxicol; 2022 Nov; 23(1):86. PubMed ID: 36443818
[TBL] [Abstract][Full Text] [Related]
30. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and
Wu L; Zhao L; Su X; Zhang P; Ling G
Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898
[TBL] [Abstract][Full Text] [Related]
31. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.
Kamel AE; Fadel M; Louis D
Int J Nanomedicine; 2019; 14():5073-5085. PubMed ID: 31371948
[TBL] [Abstract][Full Text] [Related]
32. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
33. Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against
Sato MR; Oshiro Junior JA; Machado RT; de Souza PC; Campos DL; Pavan FR; da Silva PB; Chorilli M
Drug Des Devel Ther; 2017; 11():909-921. PubMed ID: 28356717
[TBL] [Abstract][Full Text] [Related]
34. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
35. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies.
Gurumukhi VC; Bari SB
Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597
[TBL] [Abstract][Full Text] [Related]
36. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
[TBL] [Abstract][Full Text] [Related]
37. Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations.
Managuli RS; Wang JT; Faruqu FN; Kushwah V; Raut SY; Shreya AB; Al-Jamal KT; Jain S; Mutalik S
Nanomedicine (Lond); 2019 Apr; 14(7):889-910. PubMed ID: 30874464
[TBL] [Abstract][Full Text] [Related]
38. Design of hydroxy-α-sanshool loaded nanostructured lipid carriers as a potential local anesthetic.
Tan F; Xu L; Liu Y; Li H; Zhang D; Qin C; Han Y; Han J
Drug Deliv; 2022 Dec; 29(1):743-753. PubMed ID: 35244508
[TBL] [Abstract][Full Text] [Related]
39. Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy.
Jiang H; Pei L; Liu N; Li J; Li Z; Zhang S
Drug Deliv; 2016 May; 23(4):1379-82. PubMed ID: 26162024
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial Activity of Nanostructured Lipid Carriers Loaded
Fathi N; Lotfipour F; Dizaj SM; Hamishehkar H; Mohammadi M
Pharm Nanotechnol; 2020; 8(6):485-494. PubMed ID: 33407060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
